A Study to Evaluate the Clinical Efficacy and Safety of Tobradex® ST Compared to Azasite® in the Treatment of Subjects With Moderate to Severe Chronic Blepharitis

PHASE3CompletedINTERVENTIONAL

Enrollment

122

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

June 30, 2010

Conditions

Blepharitis

Interventions

DRUG

Tobradex ST

tobramycin / dexamethasone ophthalmic suspension 0.3%/0.05% 1 drop 4 times daily for 14 days

DRUG

Azasite

azithromycin 1% 1 drop twice daily for 2 days, then once daily for 12 days

Trial Locations (1)

Ora, Andover